REPROCELL News

Corporate News tagged:

Precision medicine

REPROCELL Corporate News

End of 2023 Newsletter

15 December 2023

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

01 June 2023

REPROCELL co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development

08 March 2022

UK Government’s science and innovation audit highlights REPROCELL’s work in precision medicine

14 March 2019

Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.

About REPROCELL

Make an inquiry

End of 2023 Newsletter

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

REPROCELL co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development

UK Government’s science and innovation audit highlights REPROCELL’s work in precision medicine

Subscribe to receive updates